PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -62.21% |
| Q3 2025 | 18.58% |
| Q2 2025 | -8.53% |
| Q1 2025 | 13.20% |
| Q4 2024 | 12.84% |
| Q3 2024 | 59.92% |
| Q2 2024 | -69.40% |
| Q1 2024 | -32.55% |
| Q4 2023 | 32.05% |
| Q3 2023 | -129.79% |
| Q2 2023 | 41.85% |
| Q1 2023 | 33.03% |
| Q4 2022 | -37.95% |
| Q3 2022 | -11.47% |
| Q2 2022 | -76.17% |
| Q1 2022 | 14.83% |
| Q4 2021 | 1.76% |
| Q3 2021 | 1.16% |
| Q2 2021 | -36.72% |
| Q1 2021 | 20.32% |
| Q4 2020 | -7.71% |
| Q3 2020 | -17.60% |
| Q2 2020 | 14.29% |
| Q1 2020 | 17.99% |
| Q4 2019 | 5.91% |
| Q3 2019 | 3.24% |
| Q2 2019 | -73.37% |
| Q1 2019 | 34.81% |
| Q4 2018 | 14.65% |
| Q3 2018 | 16.09% |
| Q2 2018 | 28.71% |
| Q1 2018 | -11.96% |
| Q4 2017 | -7.46% |
| Q3 2017 | -46.15% |
| Q2 2017 | 9.91% |
| Q1 2017 | -31.62% |
| Q4 2016 | 5.53% |
| Q3 2016 | 8.84% |
| Q2 2016 | 36.89% |
| Q1 2016 | -9.54% |